Christopher Cabell

Christopher Cabell

Fortune : 1 M $ au 31/10/2026

57 ans
Health Technology
Consumer Services
Commercial Services

Profil

Christopher H.
Cabell
is Chief Executive Officer at CorHepta Pharmaceuticals, Inc. since 2024.
Director at ScienceMedia, Inc. since 2020.
Independent Director at Pulmatrix, Inc. since 2020.
Member at American College of Cardiology Foundation.
President & Head-Research & Development at Inhibikase Therapeutics, Inc. starting 2025.
Formerly Chief Medical Officer & Executive Vice President at Zura Bio Ltd. from 2023 to 2024.
Chief Medical Officer & Head-Clinical Development at Emergent BioSolutions, Inc. from 2021 to 2023.
Chief Medical Officer, Head-Research & Development at Arena Pharmaceuticals, Inc. in 2020.
Senior VP & Head-Therapeutic Delivery Unit at Quintiles Transnational Corp.
from 2015 to 2017.
Chief Medical & Scientific Officer at Quintiles, Inc. (California), IQVIA RDS, Inc., and IQVIA, Inc. from 2007 to 2017.
Director at Cenduit LLC.
Director-Echocardiography Core Lab at Duke Clinical Research Institute.
Co-Chairman at US Food & Drug Administration and Cardiac Safety Research Consortium.
Associate Professor at Duke University School of Medicine.
Education includes graduate degree from Duke University, undergraduate degree from The Pennsylvania State University, and doctorate from Duke University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
15/04/2026 676 564 ( 0,48 % ) 1 M $ 31/10/2026
28/08/2026 0 ( -.--% ) - $ 31/10/2026

Postes actifs de Christopher Cabell

SociétésPosteDébut
INHIBIKASE THERAPEUTICS, INC. President 21/02/2025
PULMATRIX, INC. Directeur/Membre du Conseil 23/06/2020
Directeur/Membre du Conseil 18/02/2020
Corporate Officer/Principal 30/04/2009

Anciens postes connus de Christopher Cabell

SociétésPosteFin
ZURA BIO LIMITED Directeur Technique/Scientifique/R&D 15/01/2024
EMERGENT BIOSOLUTIONS INC. Directeur Technique/Scientifique/R&D 01/01/2023
ARENA PHARMACEUTICALS Directeur Technique/Scientifique/R&D 01/12/2020
Directeur Technique/Scientifique/R&D 01/09/2017
Directeur Technique/Scientifique/R&D 22/07/2011
Voir l'expérience en détail de Christopher Cabell

Formation de Christopher Cabell

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

68

Relations au 1er degré

18

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées18

Commercial Services

Technology Services

Health Technology

Health Services

Consumer Services

Health Technology

Consumer Services

Health Technology

Government

Health Services

Commercial Services

Technology Services

Distribution Services

Health Technology

Consumer Services

Health Technology

Cardiac Safety Research Consortium

Health Technology

  1. Bourse
  2. Insiders
  3. Christopher Cabell
🔇